Paper19429481
Epigenetic mechanisms in the biology of prostate cancer.
Schulz WA and 1 other. Semin Cancer Biol, 2009. Cited by 56 papers, by iCite.
Cite this record
ConductScience Library. Epigenetic mechanisms in the biology of prostate cancer. Papers, record 19429481. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19429481
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA Methylation | Major topic |
| Epigenesis, Genetic | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Prostatic Neoplasms | Major topic |
| Receptors, Androgen | Major topic |
| Androgens | |
| Animals | |
| Biomarkers, Tumor | |
| Humans | |
| Male | |
| Oxidoreductases, N-Demethylating | |
| Polycomb-Group Proteins | |
| Repressor Proteins |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 56 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40959108 | SETD2 and EZH2: Two epigenetic drivers of prostate cancer. | J Cancer | 2025 | https://conductscience.org/library/papers/40959108 | PubMed |
| 34977151 | Roles of Key Epigenetic Regulators in the Gene Transcription and Progression of Prostate Cancer. | Front Mol Biosci | 2021 | https://conductscience.org/library/papers/34977151 | PubMed |
| 31233548 | Screening of urine identifies PLA2G16 as a field defect methylation biomarker for prostate cancer detection. | PLoS One | 2019 | https://conductscience.org/library/papers/31233548 | PubMed |
| 28750683 | Identification of novel prostate cancer drivers using RegNetDriver: a framework for integration of genetic and epigenetic alterations with tissue-specific regulatory network. | Genome Biol | 2017 | https://conductscience.org/library/papers/28750683 | PubMed |
| 28415635 | Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target. | Oncotarget | 2017 | https://conductscience.org/library/papers/28415635 | PubMed |
| 26547439 | Correlation between the germline methylation status in ERβ promoter and the risk in prostate cancer: a prospective study. | Fam Cancer | 2016 | https://conductscience.org/library/papers/26547439 | PubMed |
| 25384337 | Global DNA hypomethylation in prostate cancer development and progression: a systematic review. | Prostate Cancer Prostatic Dis | 2015 | https://conductscience.org/library/papers/25384337 | PubMed |
| 24526064 | EZH2: not EZHY (easy) to deal. | Mol Cancer Res | 2014 | https://conductscience.org/library/papers/24526064 | PubMed |
| 24398858 | Histone H2A.Z deregulation in prostate cancer. Cause or effect? | Cancer Metastasis Rev | 2014 | https://conductscience.org/library/papers/24398858 | PubMed |
| 24213111 | Biomarkers in prostate cancer epidemiology. | Cancers (Basel) | 2011 | https://conductscience.org/library/papers/24213111 | PubMed |
| 24213107 | DNA Methylation and the HOXC6 Paradox in Prostate Cancer. | Cancers (Basel) | 2011 | https://conductscience.org/library/papers/24213107 | PubMed |
| 24179382 | Promoter methylation in prostate cancer and its application for the early detection of prostate cancer using serum and urine samples. | Biomark Cancer | 2010 | https://conductscience.org/library/papers/24179382 | PubMed |
| 23644490 | Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond. | Epigenetics | 2013 | https://conductscience.org/library/papers/23644490 | PubMed |
| 23636686 | EZH2, an epigenetic driver of prostate cancer. | Protein Cell | 2013 | https://conductscience.org/library/papers/23636686 | PubMed |
| 23555185 | Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer. | Neoplasia | 2013 | https://conductscience.org/library/papers/23555185 | PubMed |
| 23135352 | Epigenetics-related genes in prostate cancer: expression profile in prostate cancer tissues, androgen-sensitive and -insensitive cell lines. | Int J Mol Med | 2013 | https://conductscience.org/library/papers/23135352 | PubMed |
| 23016851 | Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives. | Curr Pharm Des | 2013 | https://conductscience.org/library/papers/23016851 | PubMed |
| 22952798 | Effects of chronic exposure to arsenic and estrogen on epigenetic regulatory genes expression and epigenetic code in human prostate epithelial cells. | PLoS One | 2012 | https://conductscience.org/library/papers/22952798 | PubMed |
| 22704268 | Molecular marks for epigenetic identification of developmental and cancer stem cells. | Clin Epigenetics | 2011 | https://conductscience.org/library/papers/22704268 | PubMed |
| 22596233 | Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence. | Br J Cancer | 2012 | https://conductscience.org/library/papers/22596233 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| AR | 367 | PubTator's text mining | https://conductscience.org/library/genes/367 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19429481
GET https://conductscience.org/api/papers/v1/19429481/cited_by?page=2